Home NDC 50090-5739 Acyclovir
Product NDC 50090-5739
11-digit product format 500905739
Labeler code 50090
Product ID 50090-5739_a8c46c16-ce72-4bdc-802b-a55fbff346f0
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form CAPSULE
Route ORAL
Labeler A-S Medication Solutions
Application ANDA201445
Marketing category ANDA
Marketing start 2016-10-15
Marketing end 0000-00-00
Substance ACYCLOVIR
Active strength 200 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record FDA-Initiated Inactive NDC Indexing# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50090-5739-0 50090573900 25 CAPSULE in 1 BOTTLE (50090-5739-0) 25 capsule 2021-09-29 0000-00-00 No No Current 50090-5739-1 50090573901 50 CAPSULE in 1 BOTTLE (50090-5739-1) 50 capsule 2021-09-29 0000-00-00 No No Current 50090-5739-7 50090573907 30 CAPSULE in 1 BOTTLE (50090-5739-7) 30 capsule 2021-09-02 0000-00-00 No No Current